Gut microbiota and chronic obstructive pulmonary disease: a Mendelian randomization study.

Area of Science:

• Microbiome research
• Pulmonary medicine
• Genetic epidemiology

Background:

• Emerging evidence suggests a strong association between gut microbiota composition and chronic obstructive pulmonary disease (COPD).
• The precise causal relationship between gut dysbiosis and COPD pathogenesis remains incompletely understood.

Purpose of the Study:

• To investigate the potential causal impact of gut microbiota on the risk of developing COPD.
• To identify specific bacterial taxa within the gut microbiome that may influence COPD susceptibility.

Main Methods:

• Employed a two-sample Mendelian randomization (MR) approach utilizing large-scale genome-wide association study (GWAS) data.
• Leveraged summary-level data from the MiBioGen consortium for gut microbiota and the FinnGen consortium for COPD.
• Applied the inverse variance weighted (IVW) method for primary causal inference, supplemented by pleiotropy and heterogeneity tests.

Main Results:

• The MR analysis identified nine bacterial taxa significantly associated with COPD risk.
• Genera such as *Coprococcus2*, *Oscillospira*, *Allisonella*, and Class Actinobacteria showed a protective effect against COPD.
• Conversely, Order Desulfovibrionales, Family Desulfovibrionaceae, Family Peptococcaceae, Family Victivallaceae, and Genus *Marvinbryantia* were associated with an increased risk of COPD.

Conclusions:

• This Mendelian randomization study provides evidence for a causal link between specific gut microbial communities and chronic obstructive pulmonary disease.
• The findings contribute novel insights into the gut-lung axis and the potential role of the gut microbiome in COPD development and progression.